DOID:305: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{DOID
|id=DOID:305
|name=carcinoma
|namespace=
|def="A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from epithelial cells." [url:htt...") |
No edit summary |
||
Line 2: | Line 2: | ||
|id=DOID:305 | |id=DOID:305 | ||
|name=carcinoma | |name=carcinoma | ||
|namespace= | |namespace=disease_ontology | ||
|def="A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from epithelial cells." [url:http\://en.wikipedia.org/wiki/Carcinoma] | |def="A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from epithelial cells." [url:http\://en.wikipedia.org/wiki/Carcinoma] | ||
|xref= | |xref=MSH:D002277;;NCI:C2916;;SNOMEDCT_2010_1_31:118285006;;SNOMEDCT_2010_1_31:134207000;;SNOMEDCT_2010_1_31:154433003;;SNOMEDCT_2010_1_31:188083002;;SNOMEDCT_2010_1_31:189546004;;SNOMEDCT_2010_1_31:189549006;;SNOMEDCT_2010_1_31:189559007;;SNOMEDCT_2010_1_31:269513004;;SNOMEDCT_2010_1_31:68453008;;SNOMEDCT_2010_1_31:71298006;;UMLS_CUI:C0007097;;UMLS_CUI:C0553707;;UMLS_CUI:C1368683 | ||
|is_a=DOID:0050687 | |is_a=DOID:0050687 | ||
|synonym="carcinoma" EXACT [CSP2005:2000-1867];;"epithelioma" EXACT [CSP2005:2000-5801];;"Epithelioma, malignant (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:71298006];;"malignant Epithelioma" EXACT [NCI2004_11_17:C6927];;"malignant epithelioma" EXACT [] | |synonym="carcinoma" EXACT [CSP2005:2000-1867];;"epithelioma" EXACT [CSP2005:2000-5801];;"Epithelioma, malignant (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:71298006];;"malignant Epithelioma" EXACT [NCI2004_11_17:C6927];;"malignant epithelioma" EXACT [] | ||
Line 20: | Line 20: | ||
|located_in= | |located_in= | ||
|part_of= | |part_of= | ||
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo | |||
|is_obsolete= | |||
|preceded_by= | |||
}} | }} |
Revision as of 14:00, 11 June 2012
Name: | carcinoma | ||
---|---|---|---|
Namespace: | disease_ontology | ||
Definition: | "A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from epithelial cells." [url:http\://en.wikipedia.org/wiki/Carcinoma] | ||
Xrefs: |
| ||
Synonyms: |
"carcinoma" EXACT [CSP2005:2000-1867] "epithelioma" EXACT [CSP2005:2000-5801] "Epithelioma, malignant (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:71298006] "malignant Epithelioma" EXACT [NCI2004_11_17:C6927] "malignant epithelioma" EXACT [] | ||
Alt_id: |
DOID:2428 DOID:6570 |
Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data
Parents
is_a: | DOID:0050687(cell type cancer) |
---|
Children
is a: | DOID:1749 (squamous cell carcinoma),DOID:2671 (transitional cell carcinoma),DOID:299 (adenocarcinoma),DOID:5662 (pleomorphic carcinoma) |
---|
Ontology Tree: Loaded from BioPortal
Ontorolgy tree(Small window open)
FF samples
Human (Homo sapiens)
- 10408-106B3 (lung adenocarcinoma cell line:PC-14)
- 10411-106B6 (renal cell carcinoma cell line:OS-RC-2)
- 10412-106B7 (malignant trichilemmal cyst cell line:DJM-1)
- 10415-106C1 (gall bladder carcinoma cell line:TGBC2TKB)
- 10417-106C3 (papillotubular adenocarcinoma cell line:TGBC18TKB)
- 10418-106C4 (transitional-cell carcinoma cell line:5637)
- 10419-106C5 (breast carcinoma cell line:MDA-MB-453)
- 10420-106C6 (colon carcinoma cell line:COLO-320)
- 10426-106D3 (epidermoid carcinoma cell line:A431)
- 10428-106D5 (anaplastic carcinoma cell line:8305C)
... further results Mouse (Mus musculus)
- 10408-106B3 (lung adenocarcinoma cell line:PC-14)
- 10411-106B6 (renal cell carcinoma cell line:OS-RC-2)
- 10412-106B7 (malignant trichilemmal cyst cell line:DJM-1)
- 10415-106C1 (gall bladder carcinoma cell line:TGBC2TKB)
- 10417-106C3 (papillotubular adenocarcinoma cell line:TGBC18TKB)
- 10418-106C4 (transitional-cell carcinoma cell line:5637)
- 10419-106C5 (breast carcinoma cell line:MDA-MB-453)
- 10420-106C6 (colon carcinoma cell line:COLO-320)
- 10426-106D3 (epidermoid carcinoma cell line:A431)
- 10428-106D5 (anaplastic carcinoma cell line:8305C)
Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:305 (carcinoma), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data
P-value | FFCP | Short description |
---|---|---|
2.94e-66 | FFCP PHASE1:Hg19::chr8:120221345..120221393,+#_e480e569f91ec859ccc67477be22025e | p3@MAL2 |
2.94e-66 | FFCP PHASE2:Hg19::chr8:120221345..120221393,+#_e480e569f91ec859ccc67477be22025e | p3@MAL2 |
9.17e-60 | FFCP PHASE2:Hg19::chr12:20975472..20975489,+#_fcb0c02bd1e339b5688b0e10779dba35 | p@chr12:20975472..20975489, + |
9.17e-60 | FFCP PHASE1:Hg19::chr12:20975472..20975489,+#_fcb0c02bd1e339b5688b0e10779dba35 | p@chr12:20975472..20975489, + |
6.95e-59 | FFCP PHASE2:Hg19::chr12:20975516..20975562,+#_bdfa9473d5032d75d03713599aca4f37 | p@chr12:20975516..20975562, + |
6.95e-59 | FFCP PHASE1:Hg19::chr12:20975516..20975562,+#_bdfa9473d5032d75d03713599aca4f37 | p@chr12:20975516..20975562, + |
2.8e-56 | FFCP PHASE2:Hg19::chr7:1595871..1595896,-#_71d7cc501bf27d8001283a623322f3ec | p5@TMEM184A |
2.8e-56 | FFCP PHASE1:Hg19::chr7:1595871..1595896,-#_71d7cc501bf27d8001283a623322f3ec | p5@TMEM184A |
2.92e-53 | FFCP PHASE1:Hg19::chr7:1595831..1595858,-#_878af2c488301f49eada36c0e8b5afd0 | p1@TMEM184A |
2.92e-53 | FFCP PHASE2:Hg19::chr7:1595831..1595858,-#_878af2c488301f49eada36c0e8b5afd0 | p1@TMEM184A |
8.91e-53 | FFCP PHASE1:Hg19::chr7:1595804..1595828,-#_d845ef4132d88c5f07cadd26d32f2c9f | p3@TMEM184A |
8.91e-53 | FFCP PHASE2:Hg19::chr7:1595804..1595828,-#_d845ef4132d88c5f07cadd26d32f2c9f | p3@TMEM184A |
1.09e-51 | FFCP PHASE2:Hg19::chr3:194040598..194040638,-#_7c92ddf661dc715e4a604608f6386aa1 | p@chr3:194040598..194040638, - |
1.09e-51 | FFCP PHASE1:Hg19::chr3:194040598..194040638,-#_7c92ddf661dc715e4a604608f6386aa1 | p@chr3:194040598..194040638, - |
1.28e-51 | FFCP PHASE2:Hg19::chr8:120221313..120221336,+#_7e8f458d77c9783e1f62002c0d68a125 | p5@MAL2 |
1.28e-51 | FFCP PHASE1:Hg19::chr8:120221313..120221336,+#_7e8f458d77c9783e1f62002c0d68a125 | p5@MAL2 |
3.28e-51 | FFCP PHASE1:Hg19::chr2:174562443..174562467,+#_af57c25d778f6f7ebab0f0600bea7112 | p@chr2:174562443..174562467, + |
3.28e-51 | FFCP PHASE2:Hg19::chr2:174562443..174562467,+#_af57c25d778f6f7ebab0f0600bea7112 | p@chr2:174562443..174562467, + |
5.99e-49 | FFCP PHASE2:Hg19::chr14:38064429..38064486,-#_20ded271638bde6fa09fa1ff34d51927 | p1@FOXA1 |
5.99e-49 | FFCP PHASE1:Hg19::chr14:38064429..38064486,-#_20ded271638bde6fa09fa1ff34d51927 | p1@FOXA1 |
1.76e-48 | FFCP PHASE1:Hg19::chr17:62770351..62770363,-#_9f6f90c81ff99c6ed20874b40bb98d77 | p@chr17:62770351..62770363, - |
1.76e-48 | FFCP PHASE2:Hg19::chr17:62770351..62770363,-#_9f6f90c81ff99c6ed20874b40bb98d77 | p@chr17:62770351..62770363, - |
2.63e-48 | FFCP PHASE2:Hg19::chr3:180707436..180707451,-#_375c94b527e250eb5d0456f0aca98093 | p2@DNAJC19 |
2.63e-48 | FFCP PHASE1:Hg19::chr3:180707436..180707451,-#_375c94b527e250eb5d0456f0aca98093 | p2@DNAJC19 |
2.8e-48 | FFCP PHASE1:Hg19::chr13:109917833..109917866,+#_049233a4db39cac49b7151a7bd4367bc | p@chr13:109917833..109917866, + |
2.8e-48 | FFCP PHASE2:Hg19::chr13:109917833..109917866,+#_049233a4db39cac49b7151a7bd4367bc | p@chr13:109917833..109917866, + |
3.23e-48 | FFCP PHASE2:Hg19::chr22:46022320..46022366,-#_a95c39af65aa24fc15fdbcae1992e6a8 | p@chr22:46022320..46022366, - |
3.23e-48 | FFCP PHASE1:Hg19::chr22:46022320..46022366,-#_a95c39af65aa24fc15fdbcae1992e6a8 | p@chr22:46022320..46022366, - |
3.94e-47 | FFCP PHASE1:Hg19::chr2:54784868..54784919,+#_021dec0a050cd2ca35da1c228f95d518 | p@chr2:54784868..54784919, + |
3.94e-47 | FFCP PHASE2:Hg19::chr2:54784868..54784919,+#_021dec0a050cd2ca35da1c228f95d518 | p@chr2:54784868..54784919, + |
4.99e-47 | FFCP PHASE1:Hg19::chr15:56311466..56311511,+#_1f47ea5a32af89e31db11ae26e4bd5c3 | p@chr15:56311466..56311511, + |
4.99e-47 | FFCP PHASE2:Hg19::chr15:56311466..56311511,+#_1f47ea5a32af89e31db11ae26e4bd5c3 | p@chr15:56311466..56311511, + |
6.38e-47 | FFCP PHASE1:Hg19::chr1:201979743..201979762,+#_13f3578cd46f9b4bbaa2cdb2d12cd4e1 | p1@ELF3 |
6.38e-47 | FFCP PHASE2:Hg19::chr1:201979743..201979762,+#_13f3578cd46f9b4bbaa2cdb2d12cd4e1 | p1@ELF3 |
9.96e-47 | FFCP PHASE2:Hg19::chr12:52585765..52585777,-#_efa21879bce925e5595dbaace2b67314 | p2@KRT80 |
9.96e-47 | FFCP PHASE1:Hg19::chr12:52585765..52585777,-#_efa21879bce925e5595dbaace2b67314 | p2@KRT80 |
3.03e-46 | FFCP PHASE2:Hg19::chr8:120255687..120255760,+#_0eb69a148f501989b2385c7c3def1068 | p4@MAL2 |
3.03e-46 | FFCP PHASE1:Hg19::chr8:120255687..120255760,+#_0eb69a148f501989b2385c7c3def1068 | p4@MAL2 |
5.42e-46 | FFCP PHASE1:Hg19::chr17:43503012..43503035,-#_55a87ec3d200160bedf51b4acb7e66b4 | p4@ARHGAP27 |
5.42e-46 | FFCP PHASE2:Hg19::chr17:43503012..43503035,-#_55a87ec3d200160bedf51b4acb7e66b4 | p4@ARHGAP27 |
1.07e-45 | FFCP PHASE2:Hg19::chr7:101917482..101917507,+#_59ca8e45a1711fd4f1d1d3a081ba3d4c | p6@CUX1 |
1.07e-45 | FFCP PHASE1:Hg19::chr7:101917482..101917507,+#_59ca8e45a1711fd4f1d1d3a081ba3d4c | p6@CUX1 |
1.42e-45 | FFCP PHASE1:Hg19::chr8:82644562..82644654,-#_508267ec1f3070b233f7c0115aa02cac | p2@ZFAND1 |
1.42e-45 | FFCP PHASE2:Hg19::chr8:82644562..82644654,-#_508267ec1f3070b233f7c0115aa02cac | p2@ZFAND1 |
2.28e-45 | FFCP PHASE1:Hg19::chr7:156803329..156803362,-#_39341b5cc32859293639d51a7ed0c4d2 | p1@MNX1 |
2.28e-45 | FFCP PHASE2:Hg19::chr7:156803329..156803362,-#_39341b5cc32859293639d51a7ed0c4d2 | p1@MNX1 |
2.88e-45 | FFCP PHASE1:Hg19::chr19:751122..751139,+#_dbd6dd1ac90a2099b1b6493b61a48ab9 | p1@C19orf21 |
2.88e-45 | FFCP PHASE2:Hg19::chr19:751122..751139,+#_dbd6dd1ac90a2099b1b6493b61a48ab9 | p1@C19orf21 |
1.72e-44 | FFCP PHASE1:Hg19::chr18:47376197..47376227,-#_133d5611df0592e4ad194f9ec3bd6718 | p2@MYO5B |
1.72e-44 | FFCP PHASE2:Hg19::chr18:47376197..47376227,-#_133d5611df0592e4ad194f9ec3bd6718 | p2@MYO5B |
2.93e-44 | FFCP PHASE2:Hg19::chr7:101917447..101917479,+#_b22ba3a60cf2998eaf25e2cfa7d60084 | p4@CUX1 |
2.93e-44 | FFCP PHASE1:Hg19::chr7:101917447..101917479,+#_b22ba3a60cf2998eaf25e2cfa7d60084 | p4@CUX1 |
1.26e-43 | FFCP PHASE1:Hg19::chr2:238499725..238499747,-#_24fd32b30a2a87f657a6f0bdf2bfa41d | p2@RAB17 |
1.26e-43 | FFCP PHASE2:Hg19::chr2:238499725..238499747,-#_24fd32b30a2a87f657a6f0bdf2bfa41d | p2@RAB17 |
1.31e-43 | FFCP PHASE2:Hg19::chr8:144821696..144821778,+#_cdea6a11277b81b841725508db2f0083 | p@chr8:144821696..144821778, + |
1.31e-43 | FFCP PHASE1:Hg19::chr8:144821696..144821778,+#_cdea6a11277b81b841725508db2f0083 | p@chr8:144821696..144821778, + |
1.5e-43 | FFCP PHASE2:Hg19::chr2:32264532..32264584,-#_4d1f41d3be2d66731677b437d1f45cef | p@chr2:32264532..32264584, - |
1.5e-43 | FFCP PHASE1:Hg19::chr2:32264532..32264584,-#_4d1f41d3be2d66731677b437d1f45cef | p@chr2:32264532..32264584, - |
3.61e-43 | FFCP PHASE2:Hg19::chr19:751104..751121,+#_5b2c8139a3dbdeed10de8b692c1346d2 | p2@C19orf21 |
3.61e-43 | FFCP PHASE1:Hg19::chr19:751104..751121,+#_5b2c8139a3dbdeed10de8b692c1346d2 | p2@C19orf21 |
4.96e-43 | FFCP PHASE1:Hg19::chr1:45988542..45988573,-#_041d87225f7d7b940e5002a8b4cb209c | p2@PRDX1 |
4.96e-43 | FFCP PHASE2:Hg19::chr1:45988542..45988573,-#_041d87225f7d7b940e5002a8b4cb209c | p2@PRDX1 |
7.6e-43 | FFCP PHASE2:Hg19::chr11:66139128..66139152,-#_0e5d62a735fe011282d84870a8be52a5 | p3@SLC29A2 |
7.6e-43 | FFCP PHASE1:Hg19::chr11:66139128..66139152,-#_0e5d62a735fe011282d84870a8be52a5 | p3@SLC29A2 |
1.26e-42 | FFCP PHASE1:Hg19::chr11:66139068..66139120,-#_4d8a36590aad95a87ed708df3a2c5d52 | p2@SLC29A2 |
1.26e-42 | FFCP PHASE2:Hg19::chr11:66139068..66139120,-#_4d8a36590aad95a87ed708df3a2c5d52 | p2@SLC29A2 |
1.76e-42 | FFCP PHASE1:Hg19::chr8:82644522..82644557,-#_f39c194436783e991b1b9a4bc74956fa | p4@ZFAND1 |
1.76e-42 | FFCP PHASE2:Hg19::chr8:82644522..82644557,-#_f39c194436783e991b1b9a4bc74956fa | p4@ZFAND1 |
3.06e-42 | FFCP PHASE2:Hg19::chr13:114103443..114103479,-#_3849c4e9bfdd0ab1c3f25154664844f0 | p2@ADPRHL1 |
3.06e-42 | FFCP PHASE1:Hg19::chr13:114103443..114103479,-#_3849c4e9bfdd0ab1c3f25154664844f0 | p2@ADPRHL1 |
3.8e-42 | FFCP PHASE2:Hg19::chr12:50419141..50419170,-#_e10f6273148938f42a15f4c0a71686d5 | p2@RACGAP1 |
3.8e-42 | FFCP PHASE1:Hg19::chr12:50419141..50419170,-#_e10f6273148938f42a15f4c0a71686d5 | p2@RACGAP1 |
5.75e-42 | FFCP PHASE2:Hg19::chr1:45988484..45988500,-#_8f7f788782bd8345ddfdfc9dac03b113 | p4@PRDX1 |
5.75e-42 | FFCP PHASE1:Hg19::chr1:45988484..45988500,-#_8f7f788782bd8345ddfdfc9dac03b113 | p4@PRDX1 |
6.17e-42 | FFCP PHASE1:Hg19::chr16:68260798..68260800,-#_0033052dcadf7cda6a30dc03d05d7ac7 | p@chr16:68260798..68260800, - |
6.17e-42 | FFCP PHASE2:Hg19::chr16:68260798..68260800,-#_0033052dcadf7cda6a30dc03d05d7ac7 | p@chr16:68260798..68260800, - |
8.38e-42 | FFCP PHASE1:Hg19::chr2:47596330..47596380,+#_d4789da7446258fa924a548023761e05 | p2@EPCAM |
8.38e-42 | FFCP PHASE2:Hg19::chr2:47596330..47596380,+#_d4789da7446258fa924a548023761e05 | p2@EPCAM |
1.09e-41 | FFCP PHASE2:Hg19::chr7:101917407..101917443,+#_9f587f8983e8c99fa7377c6746c55182 | p3@CUX1 |
1.09e-41 | FFCP PHASE1:Hg19::chr7:101917407..101917443,+#_9f587f8983e8c99fa7377c6746c55182 | p3@CUX1 |
1.15e-41 | FFCP PHASE1:Hg19::chr2:47596394..47596400,+#_773a3f3f2127c58d7291e7c3f21671d9 | p6@EPCAM |
1.15e-41 | FFCP PHASE2:Hg19::chr2:47596394..47596400,+#_773a3f3f2127c58d7291e7c3f21671d9 | p6@EPCAM |
2.08e-41 | FFCP PHASE2:Hg19::chr3:53033328..53033357,-#_2830df919bce7af41e737d3220e67913 | p@chr3:53033328..53033357, - |
2.08e-41 | FFCP PHASE1:Hg19::chr3:53033328..53033357,-#_2830df919bce7af41e737d3220e67913 | p@chr3:53033328..53033357, - |
3.43e-41 | FFCP PHASE2:Hg19::chr8:82644655..82644687,-#_209e65b69087ec47e4d1c2f9017e6aa8 | p3@ZFAND1 |
3.43e-41 | FFCP PHASE1:Hg19::chr8:82644655..82644687,-#_209e65b69087ec47e4d1c2f9017e6aa8 | p3@ZFAND1 |
4.76e-41 | FFCP PHASE2:Hg19::chr1:201979703..201979721,+#_c845bbb7cd42f7de1946ff5842214d39 | p2@ELF3 |
4.76e-41 | FFCP PHASE1:Hg19::chr1:201979703..201979721,+#_c845bbb7cd42f7de1946ff5842214d39 | p2@ELF3 |
5.39e-41 | FFCP PHASE1:Hg19::chr8:82644741..82644791,+#_72b918b3f4449aaf7b4235608d9ec8b3 | p2@CHMP4C |
5.39e-41 | FFCP PHASE2:Hg19::chr8:82644741..82644791,+#_72b918b3f4449aaf7b4235608d9ec8b3 | p2@CHMP4C |
5.49e-41 | FFCP PHASE2:Hg19::chr9:98189097..98189118,-#_3c510afd328e6f8c5c96ba46f3aeca25 | p1@ENST00000433644 |
5.49e-41 | FFCP PHASE1:Hg19::chr9:98189097..98189118,-#_3c510afd328e6f8c5c96ba46f3aeca25 | p1@ENST00000433644 |
5.55e-41 | FFCP PHASE2:Hg19::chr8:120220561..120220650,+#_b14553df922e9ba1cd04f08e03e13a6a | p1@MAL2 |
5.55e-41 | FFCP PHASE1:Hg19::chr8:120220561..120220650,+#_b14553df922e9ba1cd04f08e03e13a6a | p1@MAL2 |
9.06e-41 | FFCP PHASE2:Hg19::chr11:394196..394258,+#_ed107df516962fe3412fc56857d65ee8 | p1@PKP3 |
9.06e-41 | FFCP PHASE1:Hg19::chr11:394196..394258,+#_ed107df516962fe3412fc56857d65ee8 | p1@PKP3 |
1.5e-40 | FFCP PHASE2:Hg19::chr1:204347256..204347303,-#_bd22e27dc3669415f0655fd16c55f3d2 | p1@ENST00000441225 |
1.5e-40 | FFCP PHASE1:Hg19::chr1:204347256..204347303,-#_bd22e27dc3669415f0655fd16c55f3d2 | p1@ENST00000441225 |
1.69e-40 | FFCP PHASE2:Hg19::chr22:46373034..46373058,-#_e23edd540ad05e56280a1503f3ff1ac9 | p1@WNT7B |
1.69e-40 | FFCP PHASE1:Hg19::chr22:46373034..46373058,-#_e23edd540ad05e56280a1503f3ff1ac9 | p1@WNT7B |